Search Results - "Bennink, Roel J."

Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response by Rassam, Fadi, Olthof, Pim B., van Lienden, Krijn P., Bennink, Roel J., Besselink, Marc G., Busch, Olivier R., van Gulik, Thomas M.

“…Patients considered for liver resection with insufficient volume or function of the future remnant liver are candidates for portal vein embolization to allow…”
Get full text

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol by Andel, Daan, Lam, Marnix G. E. H, de Bruijne, Joep, Smits, Maarten L. J, Braat, Arthur J. A. T, Moelker, Adriaan, Vegt, Erik, Ruiter, Simeon J. S, Noordzij, Walter, Grazi, Gianluca, Vallati, Giulio E, Bennink, Roel J, van Delden, Otto M, Kranenburg, Onno W, Ijzermans, Jan N. M, Nijkamp, Maarten W, Erdmann, Joris I, Sciuto, Rosa, Hagendoorn, Jeroen, Borel Rinkes, Inne H. M

“…Abstract Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as…”
Get full text

Increased Hepatic Microvascular Density, Oxygenation, and VEGF in the Hypertrophic Lobe following Portal Vein Embolization in Rabbits by Uz, Zühre, Ergin, Bülent, Shen, Lucinda, van Lienden, Krijn P, Rassam, Fadi, Olthof, Pim B, Bennink, Roel J, Ince, Can, van Gulik, Thomas M

“…The microvascular events following portal vein embolization (PVE) are poorly understood despite the pivotal role of the microcirculation in liver regeneration…”
Get more information

Comparison of functional and volumetric increase of the future remnant liver and postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) by Rassam, Fadi, Olthof, Pim B, van Lienden, Krijn P, Bennink, Roel J, Erdmann, Joris I, Swijnenburg, Rutger-Jan, Busch, Olivier R, Besselink, Marc G, van Gulik, Thomas M

“…Portal vein embolization (PVE) is performed to induce hypertrophy of an insufficient future remnant liver (FRL) before major liver resection. Associating liver…”
Get full text

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma by Liu, Dajia, Steins, Anne, Klaassen, Remy, van der Zalm, Amber P., Bennink, Roel J., van Tienhoven, Geertjan, Besselink, Marc G., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.

“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma and a hypoxic microenvironment. Pancreatic stellate cells (PSC) are activated by…”
Get full text

Can Plasma Bile Salt, Triglycerides, and apoA-V Levels Predict Liver Regeneration? by Hoekstra, Lisette T., van Lienden, Krijn P., Schaap, Frank G., Chamuleau, Rob A. F. M., Bennink, Roel J., van Gulik, Thomas M.

“…Background Preoperative portal vein embolization (PVE) is used to increase the future remnant liver (FRL) in patients requiring extensive liver resection…”
Get full text

18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making by Anderegg, Maarten C J, de Groof, Elisabeth J, Gisbertz, Suzanne S, Bennink, Roel J, Lagarde, Sjoerd M, Klinkenbijl, Jean H G, Dijkgraaf, Marcel G W, Bergman, Jacques J G H M, Hulshof, Maarten C C M, van Laarhoven, Hanneke W M, van Berge Henegouwen, Mark I

“…Prognosis of esophageal cancer patients can be significantly improved by neoadjuvant chemoradiotherapy (nCRT). Given the aggressive nature of esophageal…”
Get full text

The ICAM‐1 antisense oligonucleotide ISIS‐3082 prevents the development of postoperative ileus in mice by The, Frans O, De Jonge, Wouter J, Bennink, Roel J, Van Den Wijngaard, Rene M, Boeckxstaens, Guy E

“…Intestinal manipulation (IM) during abdominal surgery triggers the influx of inflammatory cells, leading to postoperative ileus. Prevention of this local…”
Get full text

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study by Stroes, Charlotte I, Schokker, Sandor, Creemers, Aafke, Molenaar, Remco J, Hulshof, Maarten C C M, van der Woude, Stephanie O, Bennink, Roel J, Mathôt, Ron A A, Krishnadath, Kausilia K, Punt, Cornelis J A, Verhoeven, Rob H A, van Oijen, Martijn G H, Creemers, Geert-Jan, Nieuwenhuijzen, Grard A P, van der Sangen, Maurice J C, Beerepoot, Laurens V, Heisterkamp, Joos, Los, Maartje, Slingerland, Marije, Cats, Annemieke, Hospers, Geke A P, Bijlsma, Maarten F, van Berge Henegouwen, Mark I, Meijer, Sybren L, van Laarhoven, Hanneke W M

“…Approximately 15% to 43% of esophageal adenocarcinomas (EACs) are human epidermal growth factor receptor 2 (HER2) positive. Because dual-agent HER2 blockade…”
Get full text

Diagnostic Utility of 18F-FDG PET/CT in Inflammation of Unknown Origin by Balink, Hans, Bennink, Roel J, Veeger, Nic J.G.M, van Eck-Smit, Berthe L.F, Verberne, Hein J

“…OBJECTIVESThe goal of this multicenter retrospective study was to evaluate the contribution of F-FDG PET/CT in the diagnosis of patients with inflammation of…”
Get full text

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study by van der Wilk, Berend J., Noordman, Bo J., Neijenhuis, Lisanne K. A., Nieboer, Daan, Nieuwenhuijzen, Grard A. P., Sosef, Meindert N., Henegouwen, Mark I. van Berge, Lagarde, Sjoerd M., Spaander, Manon C. W., Valkema, Roelf, Biermann, Katharina, Wijnhoven, Bas P. L., van der Gaast, Ate, van Lanschot, J. Jan B., Doukas, Michael, Nikkessen, Suzan, Luyer, Misha, Schoon, Erik J., Roef, Mark J., van Lijnschoten, Ineke, Oostenbrug, Liekele E., Riedl, Robert G., Gisbertz, Suzanne S., Krishnadath, Kausilia K., Bennink, Roel J., Meijer, Sybren L.

“…OBJECTIVE:This study compared outcomes of patients with esophageal cancer and clinically complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT)…”
Get full text

An Alginate-Antacid Formulation Localizes to the Acid Pocket to Reduce Acid Reflux in Patients With Gastroesophageal Reflux Disease by Rohof, Wout O, Bennink, Roel J, Smout, Andre J.P.M, Thomas, Edward, Boeckxstaens, Guy E

“…Background & Aims Alginate rafts (polysaccharide polymers that precipitate into a low-density viscous gel when they contact gastric acid) have been reported to…”
Get full text

Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma by Frederiks, Charlotte N., Overwater, Anouk, Bergman, Jacques J. G. H. M., Pouw, Roos E., de Keizer, Bart, Bennink, Roel J., Brosens, Lodewijk A. A., Meijer, Sybren L., van Hillegersberg, Richard, van Berge Henegouwen, Mark I., Ruurda, Jelle P., Gisbertz, Suzanne S., Weusten, Bas L. A. M.

“…Background Selective lymphadenectomy using sentinel node-navigated surgery (SNNS) might offer a less invasive alternative to esophagectomy in patients with…”
Get full text

Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green by Overwater, Anouk, Weusten, Bas L. A. M., Ruurda, Jelle P., van Hillegersberg, Richard, Bennink, Roel J., de Keizer, Bart, Meijer, Sybren L., Brosens, Lodewijk A. A., Pouw, Roos E., Bergman, Jacques J. G. H. M., van Berge Henegouwen, Mark I., Gisbertz, Suzanne S.

“…Background Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of…”
Get full text

Hepatobiliary scintigraphy to predict postoperative liver failure after major liver resection; a multicenter cohort study in 547 patients by Olthof, Pim B., Arntz, Pieter, Truant, Stéphanie, El Amrani, Mehdi, Dasari, Bobby V.M., Tomassini, Federico, Troisi, Roberto I., Bennink, Roel J., Grunhagen, Dirk, Chapelle, Thiery, Op de Beeck, Bart, Zanoni, Lucia, Serenari, Matteo, Erdmann, Joris I.

“…This study aimed to analyze the predictive value of Hepatobiliary scintigraphy (HBS) for posthepatectomy liver failure (PHLF) after major liver resection with…”
Get full text

Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial) by Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, Stijn, van Delden, Otto M., Dibbets-Schneider, Petra, van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Catharina S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Burgmans, Mark C.

“…Purpose The aim of this study was to investigate the biodistribution of (super-)selective trans-arterial radioembolization (TARE) with holmium-166 microspheres…”
Get full text

Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function by Arntz, Pieter J.W., Deroose, Christophe M., Marcus, Charles, Sturesson, Christian, Panaro, Fabrizio, Erdmann, Joris, Manevska, Nevena, Moadel, Renee, de Geus-Oei, Lioe-Fee, Bennink, Roel J.

“…The aim of this joint EANM/SNMMI/IHPBA procedure guideline is to provide general information and specific recommendations and considerations on the use of…”
Get full text

External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy by Valkema, Maria J., Beukinga, Roelof J., Chatterjee, Avishek, Woodruff, Henry C., van Klaveren, David, Noordzij, Walter, Valkema, Roelf, Bennink, Roel J., Roef, Mark J., Schreurs, Wendy, Doukas, Michail, Lagarde, Sjoerd M., Wijnhoven, Bas P.L., Lambin, Philippe, Plukker, John T.M., van Lanschot, J. Jan B.

“…Detection of residual oesophageal cancer after neoadjuvant chemoradiotherapy (nCRT) is important to guide treatment decisions regarding standard oesophagectomy…”
Get full text

The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT/CT for selective internal radiation therapy in hepatocellular carcinoma by Labeur, Tim A, Cieslak, Kasia P, Van Gulik, Thomas M, Takkenberg, R Bart, van der Velden, Sandra, Lam, Marnix G.E.H, Klümpen, Heinz-Josef, Bennink, Roel J, van Delden, Otto M

“…BACKGROUNDStudies assessing the impact of selective internal radiation therapy (SIRT) on the regional liver function in patients with hepatocellular carcinoma…”
Get full text

Accuracy of 18 F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer by Valkema, Maria J, Noordman, Bo Jan, Wijnhoven, Bas P L, Spaander, Manon C W, Biermann, Katharina, Lagarde, Sjoerd M, Bennink, Roel J, Schreurs, Wendy M J, Roef, Mark J, Hobbelink, Monique G G, Janssen, Marcel J R, Graven, Laura H, van Lanschot, J Jan B, Valkema, Roelf

“…Our purpose was to prospectively investigate optimal evaluation of qualitative and quantitative F-FDG PET/CT in response evaluations 12-14 wk after neoadjuvant…”
Get full text